Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount ...

CONSHOHOCKEN, Pa., February 07, 2025--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC ...

(Reuters) - U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for proceeds of about $300 million. The company said that it now owns ...

(Reuters) - U.S. drugstore chain Walgreens Boots Alliance said on Thursday it has sold more shares in drug distributor Cencora for proceeds of about $300 million. The company said that it now owns a 6 ...

James Cleary; Executive Vice President and Chief Financial Officer; Cencora Inc Thank you ... and we are incredibly happy to have completed that acquisition on January 2. RCA is a leading retina ...

Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation initiative designed to provide health systems with ...

What’s going on here? Cencora has sweetened its fiscal 2025 profit forecast, capitalizing on a surge in specialty medicine demand, particularly GLP-1 drugs, exceeding market expectations. Cencora, ...

Full Year Adjusted EPS Guidance: Raised to $15.25 to $15.55. Full Year Revenue Growth Guidance: 8% to 10%. Full Year Operating Income Growth Guidance: 11.5% to 13.5%. Cencora Inc (NYSE:COR) reported a ...